DOJ Reaches Agreement With Mount Sinai to End Gender-Transition Procedures for Minors

AI-summarized · Neutrality-checked

The U.S. Department of Justice reached an agreement with the New York-based Mount Sinai Health System to cease providing puberty blockers, cross-sex hormones, and surgical gender-transition procedures to minors. Under the deal, Mount Sinai will pay a monetary penalty and dedicate $2 million toward free medical care for patients experiencing negative consequences from previous treatments. This settlement follows a January 2025 presidential order and an April 2025 memorandum that directed the Justice Department to investigate potential federal law violations, such as insurance fraud, within the pediatric gender-transition industry. Mount Sinai, which denied all allegations of liability, joins other institutions like Texas Children's Hospital and the Cleveland Clinic in reaching similar agreements with federal authorities.

Consequences

Mount Sinai will be prohibited from offering gender-transition interventions to minors as part of the agreement. The $2 million commitment is expected to provide restorative medical care for individuals reporting harm from prior treatments, mirroring similar clinics and funds established in other recent hospital settlements.

Sources

Know where. Know why.